- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Mesothelin (MSLN) is a glycosylphosphatidylinositol-anchored cell surface protein with restricted expression in normal mesothelial cells lining the pleura, peritoneum, and pericardium, but marked overexpression across multiple malignancies including mesothelioma, ovarian carcinoma, and endometrial carcinoma. Mesothelin Antibody is widely used as a tumor marker antibody due to this differential expression pattern, enabling detection of mesothelin-positive tumor cells and supporting analysis of tumor-associated antigen expression across diverse cancer types.
Mesothelin antibody, also referred to as MSLN antibody or mesothelioma-associated antigen antibody, produces characteristic membranous and cytoplasmic staining consistent with cell surface localization and proteolytic processing. In immunohistochemistry, strong staining is observed in mesothelioma and epithelial malignancies, where tumor cells demonstrate prominent surface labeling and cohesive distribution patterns. In contrast, most normal tissues demonstrate limited or focal staining, with expression primarily restricted to mesothelial surfaces and select epithelial structures, supporting a predominantly tumor-associated expression pattern.
As a tumor marker antibody, this clone enables evaluation of mesothelin expression across multiple cancer contexts. In lung mesothelioma, strong membranous staining highlights tumor cell populations and supports identification of mesothelial lineage. In endometrial carcinoma, tumor-associated expression further demonstrates the broader relevance of mesothelin as an epithelial tumor antigen. This cross-tumor expression profile allows comparative analysis of mesothelin-positive malignancies while maintaining clear contrast with non-expressing or low-expressing tissues.
This antibody is further supported by western blot validation in OVCAR-3 ovarian cancer cell lysates, where it detects a band corresponding to processed mesothelin, confirming recognition of endogenous protein. Complementing this, protein microarray specificity validation using a HuProt(TM) platform containing over 19,000 full-length human proteins demonstrates highly selective binding to mesothelin, with a dominant Z-score signal and strong separation from secondary targets. This specificity profile indicates minimal cross-reactivity and supports high-confidence target detection across applications.
Functionally, mesothelin contributes to tumor progression through cell adhesion and interaction with MUC16 (CA125), facilitating tumor cell attachment and dissemination within serosal environments. Its restricted normal tissue distribution combined with elevated expression in malignancy underlies its importance as both a diagnostic biomarker and therapeutic target. Overall, Mesothelin Antibody provides reliable, high-confidence detection of mesothelin expression, supporting tumor characterization and analysis of mesothelin-driven cancer biology.
A biotinylated version of this Mesothelin antibody is available for enhanced detection sensitivity in immunoassays.
This Mesothelin antibody is also part of a broader Mesothelin antibody panel offered by NSJ Bioreagents.
Optimal dilution of the MSLN antibody should be determined by the researcher.
A portion of amino acids 273-407 from the human protein was used as the immunogen for this Mesothelin antibody.
After reconstitution, the Mesothelin antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
MSLN antibody, Tumor marker antibody, Mesothelin antigen antibody, Mesothelioma marker antibody, CA125-binding protein antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.